Revenues of $67.8 million, up 21.3%
YOYRecord Policies in Force totaled approximately
383,200, up 11.1% YOY GAAP Diluted Earnings
per Share of $0.33, down 43.1% YOY Record
Adjusted Earnings per Share of $0.52, up 44.4% YOY
Health Insurance Innovations, Inc. (NASDAQ:HIIQ), a leading
cloud-based technology platform and distributor of affordable
individual and family health insurance and supplemental plans,
today announced financial results for the first quarter ended
March 31, 2018. The Company will host a live conference call
on Thursday, May 3, 2018, at 8:30 A.M. EST.
First Quarter 2018 Financial
Highlights
- Revenue was $67.8 million, compared to $55.9 million in the
first quarter of 2017, an increase of 21.3%.
- Total collections from members (premium equivalents) of $105.0
million compared to $90.9 million in the first quarter of 2017, an
increase of 15.5%.
- Net income was $6.0 million, compared to $8.5 million in the
first quarter of 2017, a decrease of 29.4%. Drivers include higher
stock-based compensation in the first quarter of 2018 and a
one-time tax benefit in the first quarter of 2017.
- Adjusted EBITDA (earnings before interest, taxes, depreciation
and amortization) was $11.9 million, compared to $9.7 million in
the first quarter of 2017, an increase of 22.7%.
- GAAP diluted earnings per share was $0.33, compared to $0.58 in
the first quarter of 2017, a decrease of 43.1%. Drivers are
consistent with change in net income.
- Record adjusted earnings per share, also referred to as
adjusted net income per share, or adjusted EPS, was $0.52 compared
to $0.36 in the first quarter of 2017, an increase of 44.4%.
- Record policies in force as of March 31, 2018, totaled
approximately 383,200, compared to 345,000 in the first quarter of
2017, an increase of 11.1%.
Premium equivalents, adjusted EBITDA, and
adjusted EPS are non-GAAP financial measures. See the
reconciliations of these measures to their respective most directly
comparable GAAP measure included within this press release.
2018 Full Year Guidance
The Company reaffirms its annual guidance of
revenue for 2018 to be between $290 million and $300 million or
grow approximately 15% to 20% year-over-year, adjusted EBITDA to be
between $54 million and $57 million or grow approximately 20% to
25% year-over-year and adjusted EPS to be between $2.45 and $2.55
or grow approximately 48% to 55% year-over-year. These
guidance numbers are based on the Company’s current method of
accounting for revenue. As an emerging growth company, it
will be adopting the revised revenue recognition standard, known as
ASC 606, in the fourth quarter of 2018.
“Following a Q4 of 2017 that exceeded all
expectations due to the shortened open enrollment period, the first
quarter of 2018 has performed as expected, and we have record
policies in force coupled with an outstanding compliance
performance. As our market continues to evolve our first quarter
provides an excellent foundation for the launch of our next
generation of technology and the rest of 2018,” said Gavin
Southwell, HIIQ's Chief Executive Officer and President.
First Quarter 2018 Financial Discussion
First quarter revenues of $67.8 million
increased 21.3%, compared to the first quarter in 2017, driven by
an increase in policies in force, favorable commission margins, and
improved discount benefit plan offerings.
Total selling, general & administrative
expense ("SG&A") was $16.2 million (23.9% of revenues) in the
first quarter of 2018, compared to $15.3 million (27.4% of
revenues) in the same period in 2017. Core SG&A, defined as
total SG&A adjusted for stock-based compensation, transaction
costs, severance, restructuring and other costs, and marketing
leads and advertising expense, was $11.0 million (16.2% of
revenues) in the first quarter of 2018, compared to $9.8 million
(17.5% of revenues) in the same period in 2017. A reconciliation of
Core SG&A to SG&A is included within this press
release.
Net income was $6.0 million in the first quarter
of 2018, compared to $8.5 million in the same period in 2017, a
decrease of 29.4%. First quarter 2017 included a one-time
approximate $3.3 million tax benefit related to the early adoption
of an accounting policy related to share-based payment
transactions. Additionally, stock-based compensation was $1.8
million higher in the first quarter of 2018 as compared to the
prior year period. EBITDA was $8.9 million in the first quarter of
2018, compared to $8.0 million in the same period in 2017, an
increase of 11.3%.
Adjusted EBITDA was $11.9 million in the first
quarter of 2018, an increase of 22.7% compared to $9.7 million in
the same period in 2017. Adjusted EBITDA as a percentage of revenue
was 17.6% in the first quarter of 2018, compared to 17.4% in the
same period in 2017. Adjusted EBITDA is calculated by taking EBITDA
and adjusting for non-cash items such as stock-based compensation
and items that are not part of regular operating activities,
including tax receivable adjustments, severance, restructuring, and
acquisition costs. A reconciliation of net income to EBITDA and
adjusted EBITDA for the first quarter of 2018 and 2017 is included
within this press release.
GAAP diluted EPS for the first quarter of 2018
was $0.33, compared to $0.58 in the same period in 2017. First
quarter 2017 GAAP diluted EPS included a benefit that resulted from
the above-described early adoption of an accounting policy related
to share-based payment transactions. Additionally, the higher
stock-based compensation in the first quarter of 2018 had an
unfavorable impact on GAAP diluted EPS.
Adjusted EPS for the first quarter of 2018 was
$0.52, compared to $0.36 in 2017. The increase in Adjusted EPS was
driven by revenue from greater policies in force as well as a lower
pro-forma statutory tax rate of 24%, compared to 38% used in the
prior period. A reconciliation of net income to adjusted net income
per share is included within this press release.
The Company makes advances to distributors based
on actual sales. These advanced commissions assist distributors
with working capital. The Company recovers advances on an ongoing
basis from future commissions on premiums, which are collected over
the period in which policies renew. At March 31, 2018, the short-
and long-term advanced commission balance was $38.1 million, a $1.4
million decrease from the December 31, 2017 year-end balance
of $39.5 million.
Cash and cash equivalents as of March 31,
2018 totaled $41.9 million, an increase of $1.0 million from the
December 31, 2017 year-end balance. The Company reclassified
in-transit credit card and ACH receipts previously included in
accounts receivable, net, prepaid expenses and other current assets
on the balance sheet to cash and cash equivalents. The change
resulted in a $1.6 million increase in cash and cash equivalents at
the beginning of the first quarter 2018 and a $2.4 million increase
to cash and cash equivalents at the end of the period.
Regulatory Update
As previously disclosed, the Company is the
subject of a multistate market conduct examination. The Company has
been cooperating with all regulatory inquiries and as of May 2,
2018, no findings of any sort have been formally or informally
communicated to the Company by the examiners.
Conference Call and Webcast
The Company will host an earnings conference
call on May 3, 2018 at 8:30 A.M. Eastern time. All interested
parties can join the call by dialing (877) 407-9039 or
(201) 689-8470; the conference ID is 13679140. A webcast
of the call may be accessed in the Investor Relations section of
Health Insurance Innovations’ website at
http://investor.hiiquote.com/events.cfm. An archive of the call
will be available for 30 days through the same website.
About Health Insurance Innovations, Inc.
(HIIQ)
HIIQ is a market leading cloud-based technology
platform and distributor of innovative health insurance products
that are affordable and meet the consumer's needs. HIIQ helps
develop insurance products through our relationships with
best-in-class insurance companies and markets them via its broad
distribution network of third party licensed insurance agents
across the nation, its call center network and its unique online
capability. Additional information about HIIQ can be found at
HiiQuote.com. HIIQ’s Consumer Division includes
AgileHealthInsurance.com, a website for researching, comparing and
purchasing short-term health insurance products online and
HealthPocket.com, a free website that compares and ranks all health
insurance plans, and uses objective data to publish unbiased health
insurance market analyses and other consumer advocacy research.
Forward-Looking Statements
This press release contains "forward-looking
statements" within the meaning of the U.S. Private Securities
Litigation Reform Act of 1995. Forward-looking statements are
statements other than historical fact, and may include statements
relating to goals, plans and projections regarding new markets,
products, services, growth strategies, anticipated trends in our
business and anticipated changes and developments in the United
States health insurance system and laws. Forward-looking statements
are based on HIIQ’s current assumptions, expectations and beliefs
are generally identifiable by use of words “may,” “might,” “will,”
“should,” “expects,” “plans,” “anticipates,” “believes,”
“estimates,” “predicts,” “potential” or “continue,” or similar
expressions and involve significant risks and uncertainties that
could cause actual results, developments and business decisions to
differ materially from those contemplated by these statements.
These risks and uncertainties include, among other things, our
ability to maintain relationships and develop new relationships
with health insurance carriers and distributors, our ability to
retain our members, the demand for products offered through our
platform, state regulatory oversight and examinations of us and our
carriers and distributors, legal and regulatory compliance by our
carriers and distributors, the amount of commissions paid to us or
changes in health insurance plan pricing practices, competition,
changes and developments in the United States health insurance
system and laws, and HIIQ’s ability to adapt to them, the ability
to maintain and enhance our name recognition, difficulties arising
from acquisitions or other strategic transactions, and our ability
to build the necessary infrastructure and processes to maintain
effective controls over financial reporting. These and other risk
factors that could cause actual results to differ materially from
those expressed or implied in our forward-looking statements will
be discussed in HIIQ's Annual Report on Form 10-K filed with the
Securities and Exchange Commission (SEC) as well as other documents
that may be filed by HIIQ from time to time with the Securities and
Exchange Commission, which are available at www.sec.gov. Any
forward-looking statement made by us in this press release is based
only on information currently available to us and speaks only as of
the date on which it is made. You should not rely on any
forward-looking statement as representing our views in the future.
We undertake no obligation to publicly update any forward-looking
statement, whether written or oral, that may be made from time to
time, whether as a result of new information, future developments
or otherwise.
Non-GAAP Financial
Information
To supplement HIIQ’s financial information
presented in accordance with generally accepted accounting
principles in the United States of America, or GAAP, HIIQ presents
certain financial measures that are not prepared in accordance with
GAAP, including premium equivalents, adjusted EBITDA, adjusted EPS,
and Core SG&A. These non-GAAP financial measures, which are
defined below, should not be considered in isolation from, or as a
substitute for, financial information prepared in accordance with
GAAP. These non-GAAP financial measures are not based on any
standardized methodology prescribed by GAAP and are not necessarily
comparable to similarly-titled measures presented by other
companies.
HIIQ is presenting these non-GAAP financial
measures to assist investors in seeing HIIQ’s operating results
through the eyes of management and because HIIQ believes that these
measures provide a useful tool for investors to use in assessing
HIIQ’s operating performance against prior period operating results
and against business objectives. HIIQ uses the non-GAAP financial
measures in evaluating its operating results and for financial and
operational decision-making purposes.
The accompanying tables provide more detail on
the GAAP financial measures that are most directly comparable to
the non-GAAP financial measures described above and the related
reconciliations between these financial measures.
HEALTH INSURANCE INNOVATIONS,
INC.Condensed Consolidated Balance
Sheets($ in thousands, except share and per share
data)
|
March 31, 2018 |
|
December 31, 2017 |
|
(unaudited) |
|
|
Assets |
|
|
|
Current assets: |
|
|
|
Cash and
cash equivalents |
$ |
41,926 |
|
|
$ |
40,907 |
|
Restricted cash |
15,385 |
|
|
14,920 |
|
Accounts
receivable, net, prepaid expenses and other current assets |
1,979 |
|
|
2,227 |
|
Advanced
commissions, net |
37,061 |
|
|
39,549 |
|
Income
taxes receivable |
633 |
|
|
— |
|
Total current
assets |
96,984 |
|
|
97,603 |
|
Property and equipment,
net |
5,578 |
|
|
5,408 |
|
Goodwill |
41,076 |
|
|
41,076 |
|
Intangible assets,
net |
5,478 |
|
|
5,942 |
|
Deferred tax
assets |
14,698 |
|
|
14,960 |
|
Other assets |
1,098 |
|
|
96 |
|
Total
assets |
$ |
164,912 |
|
|
$ |
165,085 |
|
|
|
|
|
Liabilities and
stockholders’ equity |
|
|
|
Current
liabilities: |
|
|
|
Accounts
payable and accrued expenses |
$ |
32,822 |
|
|
$ |
39,725 |
|
Deferred
revenue |
268 |
|
|
662 |
|
Income
taxes payable |
— |
|
|
787 |
|
Due to
member |
1,137 |
|
|
1,775 |
|
Other
current liabilities |
7 |
|
|
5 |
|
Total
current liabilities |
34,234 |
|
|
42,954 |
|
Due to member |
15,096 |
|
|
15,096 |
|
Other liabilities |
32 |
|
|
34 |
|
Total
liabilities |
49,362 |
|
|
58,084 |
|
Commitments and
contingencies |
|
|
|
Stockholders’
equity: |
|
|
|
Class A common
stock (par value $0.001 per share, 100,000,000 shares authorized;
12,915,760 and 12,731,758 shares issued as of March 31, 2018 and
December 31, 2017, respectively; 12,533,874 and 12,350,981 shares
outstanding as of March 31, 2018 and December 31, 2017,
respectively) |
13 |
|
|
13 |
|
Class B common stock
(par value $0.001 per share, 20,000,000 shares authorized;
3,841,667 shares issued and outstanding as of March 31, 2018 and
December 31, 2017) |
4 |
|
|
4 |
|
Preferred stock (par
value $0.001 per share, 5,000,000 shares authorized; no shares
issued and outstanding as of March 31, 2018 and December 31,
2017) |
— |
|
|
— |
|
Additional paid-in
capital |
74,594 |
|
|
71,770 |
|
Treasury stock, at cost
(381,886 and 380,777 shares as of March 31, 2018 and December 31,
2017, respectively) |
(6,923 |
) |
|
(6,887 |
) |
Retained
earnings |
23,451 |
|
|
19,305 |
|
Total
Health Insurance Innovations, Inc. stockholders’ equity |
91,139 |
|
|
84,205 |
|
Noncontrolling
interests |
24,411 |
|
|
22,796 |
|
Total
stockholders’ equity |
115,550 |
|
|
107,001 |
|
Total
liabilities and stockholders' equity |
$ |
164,912 |
|
|
$ |
165,085 |
|
|
|
|
|
|
|
|
|
HEALTH INSURANCE INNOVATIONS,
INC.
Condensed Consolidated Statements of
Income (unaudited)($ in thousands, except share
and per share data)
|
Three Months Ended March 31, |
|
2018 |
|
2017 |
Revenues (premium
equivalents of $104,976 and $90,940 for the three months ended
March 31, 2018 and 2017, respectively) |
$ |
67,750 |
|
|
$ |
55,868 |
|
Operating
expenses: |
|
|
|
Third-party commissions |
41,212 |
|
|
31,435 |
|
Credit
card and ACH fees |
1,377 |
|
|
1,183 |
|
Selling,
general and administrative |
16,213 |
|
|
15,257 |
|
Depreciation and amortization |
1,165 |
|
|
938 |
|
Total
operating expenses |
59,967 |
|
|
48,813 |
|
Income
from operations |
7,783 |
|
|
7,055 |
|
|
|
|
|
Other (income)
expense: |
|
|
|
Interest
income |
(26 |
) |
|
(1 |
) |
Other
expense |
28 |
|
|
3 |
|
Net
income before income taxes |
7,781 |
|
|
7,053 |
|
Provision
(benefit) for income taxes |
1,796 |
|
|
(1,469 |
) |
Net income |
5,985 |
|
|
8,522 |
|
Net
income attributable to noncontrolling interests |
1,839 |
|
|
2,688 |
|
Net income attributable
to Health Insurance Innovations, Inc. |
$ |
4,146 |
|
|
$ |
5,834 |
|
|
|
|
|
Per share
data: |
|
|
|
Net income per
share attributable to Health Insurance Innovations,
Inc. |
|
|
|
Basic |
$ |
0.36 |
|
|
$ |
0.66 |
|
Diluted |
$ |
0.33 |
|
|
$ |
0.58 |
|
Weighted
average Class A common shares outstanding |
|
|
|
Basic |
11,589,777 |
|
|
8,892,239 |
|
Diluted |
12,658,277 |
|
|
10,051,369 |
|
|
|
|
|
|
|
HEALTH INSURANCE INNOVATIONS,
INC.
Condensed Consolidated Statements of Cash
Flows (unaudited)($ in thousands, except share and
per share data)
|
Three Months Ended March 31, |
|
2018 |
|
2017 |
Operating
activities: |
|
|
|
Net income |
$ |
5,985 |
|
|
$ |
8,522 |
|
Adjustments to
reconcile net income to net cash provided by operating
activities: |
|
|
|
Stock-based compensation |
2,633 |
|
|
821 |
|
Depreciation and amortization |
1,165 |
|
|
938 |
|
Deferred
income taxes |
262 |
|
|
309 |
|
Changes in operating
assets and liabilities: |
|
|
|
Decrease
(increase) in accounts receivable, prepaid expenses and other
assets |
261 |
|
|
(844 |
) |
Decrease
in advanced commissions |
1,473 |
|
|
1,287 |
|
Increase
in income taxes receivable |
(633 |
) |
|
(1,645 |
) |
Decrease
in income taxes payable |
(787 |
) |
|
(2,121 |
) |
Increase
in accounts payable, accrued expenses and other liabilities |
(6,903 |
) |
|
(677 |
) |
(Decrease) increase in deferred revenue |
(394 |
) |
|
46 |
|
Net cash provided by
operating activities |
3,062 |
|
|
6,636 |
|
Investing
activities: |
|
|
|
Capitalized internal-use software and website development
costs |
(570 |
) |
|
(669 |
) |
Purchases
of property and equipment |
(113 |
) |
|
(14 |
) |
Net cash used in
investing activities |
(683 |
) |
|
(683 |
) |
Financing
activities: |
|
|
|
Payments
for noncompete obligation |
— |
|
|
(48 |
) |
Class A
common stock withheld in treasury from restricted share
vesting |
(36 |
) |
|
(185 |
) |
Issuances
of Class A common stock under equity compensation plans |
3 |
|
|
9 |
|
Distributions to member |
(862 |
) |
|
(1,197 |
) |
Net cash used in
financing activities |
(895 |
) |
|
(1,421 |
) |
Net increase in cash
and cash equivalents, and restricted cash |
1,484 |
|
|
4,532 |
|
Cash and cash
equivalents, and restricted cash at beginning of period |
55,827 |
|
|
25,370 |
|
Cash and cash
equivalents, and restricted cash at end of period |
$ |
57,311 |
|
|
$ |
29,902 |
|
|
|
|
|
Supplemental
cash flow information: |
|
|
|
Cash paid
during the period for: |
|
|
|
Income
taxes, net |
$ |
2,969 |
|
|
$ |
1,986 |
|
Interest |
1 |
|
|
4 |
|
Non-cash
investing activities: |
|
|
|
Capitalized stock-based compensation |
$ |
188 |
|
|
$ |
— |
|
Non-cash
financing activities: |
|
|
|
Change in
due to member related to Exchange Agreement |
$ |
— |
|
|
$ |
18,619 |
|
Change in
deferred tax asset related to Exchange Agreement |
— |
|
|
(20,732 |
) |
Issuance
of Class A common stock in a private offering related to Exchange
Agreement |
— |
|
|
16,484 |
|
Exchange
of Class B membership interests related to Exchange Agreement |
— |
|
|
(14,371 |
) |
Declared
but unpaid distribution to member of Health Plan Intermediaries,
LLC |
— |
|
|
2,695 |
|
|
|
|
|
|
|
Reconciliation of Net Income to EBITDA
and Adjusted EBITDA(unaudited)($
in thousands)
|
Three Months Ended March 31, |
|
2018 |
|
2017 |
Net income |
$ |
5,985 |
|
|
$ |
8,522 |
|
Interest income |
(26 |
) |
|
(1 |
) |
Depreciation and
amortization |
1,165 |
|
|
938 |
|
Provision (benefit) for
income taxes |
1,796 |
|
|
(1,469 |
) |
EBITDA
(1) |
8,920 |
|
|
7,990 |
|
Non-cash stock-based
compensation |
2,633 |
|
|
821 |
|
Transaction costs |
56 |
|
|
306 |
|
Severance,
restructuring and other charges |
287 |
|
|
533 |
|
Adjusted
EBITDA (2) |
$ |
11,896 |
|
|
$ |
9,650 |
|
|
|
|
|
|
|
|
|
Reconciliation of Net Income to Adjusted
Net Income per
Share(unaudited) ($ in
thousands except per share data)
|
Three Months Ended March 31, |
|
2018 |
|
2017 |
Net income |
$ |
5,985 |
|
|
$ |
8,522 |
|
Interest income |
(26 |
) |
|
(1 |
) |
Amortization |
464 |
|
|
511 |
|
Provision (benefit) for
income taxes |
1,796 |
|
|
(1,469 |
) |
Non-cash stock-based
compensation |
2,633 |
|
|
821 |
|
Transaction costs |
56 |
|
|
306 |
|
Severance,
restructuring and other charges |
287 |
|
|
533 |
|
Adjusted
pre-tax income |
11,195 |
|
|
9,223 |
|
Pro forma income
taxes |
(2,687 |
) |
|
(3,505 |
) |
Adjusted
net income (3) |
$ |
8,508 |
|
|
$ |
5,718 |
|
Total weighted average
diluted share count |
16,500 |
|
|
16,093 |
|
Adjusted net income per
share (4) |
$ |
0.52 |
|
|
$ |
0.36 |
|
|
|
|
|
|
|
|
|
- EBITDA is defined as net income before interest expense, income
taxes and depreciation and amortization. We have included EBITDA in
this report because it is a key measure used by our management and
Board of Directors to understand and evaluate our core operating
performance and trends, to prepare and approve our annual budget
and to develop short- and long-term operational plans. In
particular, the exclusion of certain expenses in calculating EBITDA
can provide a useful measure for period-to-period comparisons of
our business. However, EBITDA does not represent, and should not be
considered as, an alternative to net income or cash flows from
operations, each as determined in accordance with generally
accepted accounting principles in the United States of America
(“GAAP”). Other companies may calculate EBITDA differently than we
do. EBITDA has limitations as an analytical tool, and you should
not consider it in isolation or as a substitute for analysis of our
results as reported under GAAP.
- To calculate adjusted EBITDA, we calculate EBITDA, which is
then further adjusted for non-cash items such as stock-based
compensation and items that are not part of regular operating
activities, including tax receivable adjustments, severance,
restructuring, and acquisition costs. Adjusted EBITDA does not
represent, and should not be considered as, an alternative to net
income or cash flows from operations, each as determined in
accordance with GAAP. We have presented adjusted EBITDA because we
consider it an important supplemental measure of our performance
and believe that it is frequently used by analysts, investors and
other interested parties in the evaluation of companies. Other
companies may calculate adjusted EBITDA differently than we do.
Adjusted EBITDA has limitations as an analytical tool, and you
should not consider it in isolation or as a substitute for analysis
of our results as reported under GAAP.
- To calculate adjusted net income, we calculate net income then
add back amortization (but not depreciation), interest, tax
expense, non-cash items such as non-cash stock-based compensation
and other items that are not part of regular operating activities,
including, tax receivable adjustments, severance, restructuring,
and acquisition costs. From adjusted pre-tax net income we apply a
pro-forma tax expense calculated at an assumed rate of 24% and 38%
for the first quarter in 2018 and 2017, respectively. We believe
that when measuring Company and executive performance against the
adjusted net income measure, applying a pro forma tax rate better
reflects the performance of the Company without regard to the
Company’s organizational tax structure. We have included adjusted
net income in this report because it is a key performance measure
used by our management to understand and evaluate our core
operating performance and trends and because we believe it is
frequently used by analysts, investors and other interested parties
in their evaluation of our company. Other companies may calculate
this measure differently than we do. Adjusted net income has
limitations as an analytical tool, and you should not consider it
in isolation or substitution for earnings per share as reported
under GAAP.
- Adjusted net income per share is computed by dividing adjusted
net income by the total number of diluted Class A and Class B
shares of our common stock for each period. We have included
adjusted net income per share in this report because it is a key
measure used by our management to understand and evaluate our core
operating performance and trends and because we believe it is
frequently used by analysts, investors and other interested parties
in the evaluation of companies. Other companies may calculate this
measure differently than we do. Adjusted net income per share has
limitations as an analytical tool, and you should not consider it
in isolation or as a substitute for earnings per share as reported
under GAAP.
Reconciliation of Premium Equivalents to
Revenues(unaudited) ($ in
thousands)
|
Three Months Ended March 31, |
|
2018 |
|
2017 |
Premium equivalents
(1) |
$ |
104,976 |
|
|
$ |
90,940 |
|
Less risk premium |
35,546 |
|
|
33,541 |
|
Less amounts earned by
third party obligors |
1,680 |
|
|
1,531 |
|
Revenues |
$ |
67,750 |
|
|
$ |
55,868 |
|
|
|
|
|
|
|
|
|
- Premium equivalents is defined as our total collections,
including the combination of premiums, fees for discount benefit
plans, enrollment fees, and third-party commissions and referral
fees. All amounts not paid out as risk premium to carriers or paid
out to other third-party obligors are considered to be revenues for
financial reporting purposes. We have included premium equivalents
in this report because it is a key measure used by our management
to understand and evaluate our core operating performance and
trends, to prepare and approve our annual budget and to develop
short- and long-term operational plans. In particular, the
inclusion of premium equivalents can provide a useful measure for
period-to-period comparisons of our business. This financial
measurement is considered a non-GAAP financial measure and is not
recognized under generally accepted accounting principles in the
United States of America (“GAAP”) and should not be used as, and is
not an alternative to, revenues as a measure of our operating
performance.
Summary of Selected
Metrics(unaudited)($ in
thousands)
|
Submitted Applications during the
Three Months Ended March 31, |
|
|
|
|
|
|
2018 |
|
2017 |
|
Change |
IFP |
92,000 |
|
117,100 |
|
(21.4 |
)% |
Supplemental
products |
64,700 |
|
88,300 |
|
(26.7 |
)% |
Total |
156,700 |
|
205,400 |
|
(23.7 |
)% |
|
|
|
|
|
|
|
|
Policies in Force Three Months Ended March
31, |
|
|
|
2018 |
|
2017 |
|
Change |
IFP |
192,300 |
|
|
173,700 |
|
|
10.7 |
% |
Supplemental
products |
190,900 |
|
|
171,300 |
|
|
11.4 |
% |
Total |
383,200 |
|
|
345,000 |
|
|
11.1 |
% |
|
|
|
|
|
|
|
|
|
|
Submitted IFP Applications by
Channel |
|
Q1’17 |
|
Q2’17 |
|
Q3’17 |
|
Q4’17 |
|
Q1’18 |
eCommerce |
31,800 |
|
13,500 |
|
20,600 |
|
27,200 |
|
18,900 |
All Others |
85,300 |
|
82,400 |
|
72,500 |
|
98,600 |
|
73,100 |
Total |
117,100 |
|
95,900 |
|
93,100 |
|
125,800 |
|
92,000 |
|
|
|
|
|
|
|
|
|
|
|
Core SG&A as a Percentage of
Revenue |
|
Q1’17 |
|
Q2’17 |
|
Q3’17 |
|
Q4’17 |
|
Q1’18 |
Total SG&A |
$ |
15,257 |
|
|
$ |
14,697 |
|
|
$ |
15,503 |
|
|
$ |
18,989 |
|
|
$ |
16,213 |
|
Less: Stock-based
compensation |
|
821 |
|
|
|
934 |
|
|
|
2,682 |
|
|
|
2,967 |
|
|
|
2,633 |
|
Less (add): Transaction
costs |
|
306 |
|
|
|
450 |
|
|
|
5 |
|
|
|
(16 |
) |
|
|
56 |
|
Less: Severance,
restructuring and other charges |
|
533 |
|
|
|
363 |
|
|
|
238 |
|
|
|
672 |
|
|
|
287 |
|
Less: Marketing and
Advertising |
|
3,787 |
|
|
|
1,800 |
|
|
|
2,249 |
|
|
|
3,657 |
|
|
|
2,232 |
|
Core SG&A (1) |
$ |
9,810 |
|
|
$ |
11,150 |
|
|
$ |
10,329 |
|
|
$ |
11,709 |
|
|
$ |
11,005 |
|
% of Revenue |
|
17.6 |
% |
|
|
18.0 |
% |
|
|
16.3 |
% |
|
|
16.8 |
% |
|
|
16.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Core SG&A is defined as total SG&A adjusted for
stock-based compensation, transaction costs, severance,
restructuring and other costs, and marketing leads and advertising
expense.
Contacts: |
Health
Insurance Innovations, Inc.: |
Michael
HershbergerChief Financial Officer(813)
397-1187mhershberger@hiiquote.com |
|
Investor
Contact: |
John
EvansPIR Communications(415) 309-0230IR@hiiquote.com |
|
Media
Contact for AgileHealthInsurance.com& HealthPocket.com: |
Kevin
McVickerKmvicker@sbpublicaffairs.com |
|
Media
Contact for HealthPocket.com: |
Cassandre
DurocherCdurocher@sbpublicaffairs.com |
|
Health Insurance Innovat... (NASDAQ:HIIQ)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Health Insurance Innovat... (NASDAQ:HIIQ)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024